ClinicalTrials.govpublic full text
Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia
infectious pneumonia, severe covid-19, covid-19, sars-cov-2, infectious pneumonia acquired in the community (cap), interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 813918
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.